指南与共识复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

院内心搏骤停出院存活率与长期存活率的相关性:来自Get With The Guidelines®-复苏登记研究的见解

Correlation between hospital rates of survival to discharge and long-term survival for in-hospital cardiac arrest: Insights from Get With The Guidelines®-Resuscitation registry.
指南 / 共识 · Resuscitation · 2024-07-18
一句话结论在472家医院≥65岁院内心搏骤停患者中,医院出院风险标准化存活率与30天风险标准化存活率强相关(加权Kappa 0.72),作者认为出院存活率可作为30天出院的合理替代指标用于Medicare基准评价。

该研究基于Get With The Guidelines®-复苏登记研究,纳入2000-2012年472家医院≥65岁院内心搏骤停且可链接Medicare文件的患者56,231例(年龄77.2±7.5岁,女性25,206例[44.8%]),构建分层logistic回归模型计算各医院出院时及30天、1年、3年风险标准化存活率(RSSR),用加权Kappa评价院内与长期RSSR的一致性。结果显示10,536例(18.7%)存活至出院,8,485例(15.1%)存活至出院后30天;出院、30天、1年、3年RSSR中位数分别为18.6%(IQR 16.7-20.4%)、14.9%(13.2-16.7%)、10.3%(9.1-12.1%)、7.6%(6.8-8.8%);出院RSSR与30天、1年、3年RSSR的加权Kappa分别为0.72(95%CI 0.68-0.76)、0.56(0.50-0.61)、0.47(0.41-0.53)。作者认为出院RSSR与30天RSSR强相关但随时间减弱,出院RSSR可能是30天出院后存活的合理替代指标,可供Medicare在不收集30天存活数据的情况下用于该病的医院绩效基准评价。

要点

  • 56,231例≥65岁院内心搏骤停患者中,10,536例(18.7%)存活至出院,8,485例(15.1%)存活至出院后30天。
  • 医院出院RSSR与30天RSSR的加权Kappa为0.72(95%CI 0.68-0.76),提示强相关。
  • 出院RSSR与1年、3年RSSR的加权Kappa分别为0.56(0.50-0.61)和0.47(0.41-0.53),相关性随时间减弱。
  • 出院、30天、1年、3年RSSR中位数分别为18.6%(IQR 16.7-20.4%)、14.9%(13.2-16.7%)、10.3%(9.1-12.1%)、7.6%(6.8-8.8%)。
  • 作者认为出院RSSR可能是30天出院后存活的合理替代指标,可供Medicare在不收集30天存活数据的情况下用于该病的医院绩效基准评价。

适用人群与场景

  • 2000-2012年Get With The Guidelines®-复苏登记研究中472家医院≥65岁院内心搏骤停患者,且可链接Medicare文件获取出院后存活数据。

研究设计与关键结果

  • 研究类型为基于Get With The Guidelines®-复苏登记研究的队列分析,纳入472家医院56,231例Medicare受益人(年龄77.2±7.5岁,女性25,206例[44.8%])。
  • 10,536例(18.7%)存活至出院,8,485例(15.1%)存活至出院后30天。
  • 出院、30天、1年、3年RSSR中位数分别为18.6%(IQR 16.7-20.4%)、14.9%(13.2-16.7%)、10.3%(9.1-12.1%)、7.6%(6.8-8.8%)。
  • 医院出院RSSR与30天、1年、3年RSSR的加权Kappa分别为0.72(95%CI 0.68-0.76)、0.56(0.50-0.61)、0.47(0.41-0.53)。

证据类型、等级与局限

  • 证据类型:基于Get With The Guidelines®-复苏登记研究的队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,医院院内心搏骤停出院RSSR可能是其30天出院后存活的合理替代指标,可供Medicare在不收集30天存活数据的情况下用于该病的医院绩效基准评价。

指南或共识出处

  • Get With The Guidelines®-复苏登记研究(Get With The Guidelines®-Resuscitation registry)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Given challenges in collecting long-term outcomes for survivors of in-hospital cardiac arrest (IHCA), most studies have focused on in-hospital survival. We evaluated the correlation between a hospital's risk-standardized survival rate (RSSR) at hospital discharge for IHCA with its RSSR for long-term survival.

METHODS: We identified patients ≥65 years of age with IHCA at 472 hospitals in Get With The Guidelines®-Resuscitation registry during 2000-2012, who could be linked to Medicare files to obtain post-discharge survival data. We constructed hierarchical logistic regression models to compute RSSR at discharge, and 30-day, 1-year, and 3-year RSSRs for each hospital. The association between in-hospital and long-term RSSR was evaluated with weighted Kappa coefficients.

RESULTS: Among 56,231 Medicare beneficiaries (age 77.2 ± 7.5 years and 25,206 [44.8%] women), 10,536 (18.7%) survived to discharge and 8,485 (15.1%) survived to 30 days after discharge. Median in-hospital, 30-day, 1-year, and 3-year RSSRs were 18.6% (IQR, 16.7-20.4%), 14.9% (13.2-16.7%), 10.3% (9.1-12.1%), and 7.6% (6.8-8.8%), respectively. The weighted Kappa coefficient for the association between a hospital's RSSR at discharge with its 30-day, 1-year, and 3-year RSSRs were 0.72 (95% CI, 0.68-0.76), 0.56 (0.50-0.61), and 0.47 (0.41-0.53), respectively.

CONCLUSIONS: There was a strong correlation between a hospital's RSSR at discharge and its 30-day RSSR for IHCA, although this correlation weakens over time. Our findings suggest that a hospital's RSSR at discharge for IHCA may be a reasonable surrogate of its 30-day post-discharge survival and could be used by Medicare to benchmark hospital performance for this condition without collecting 30-day survival data.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Khera R, Aminorroaya A, Kennedy KF, et al. Correlation between hospital rates of survival to discharge and long-term survival for in-hospital cardiac arrest: Insights from Get With The Guidelines®-Resuscitation registry. Resuscitation. 2024. PMID: 39029583. doi:10.1016/j.resuscitation.2024.110322

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。